New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Read more

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

A recent study, currently available on the bioRxiv* preprint server, indicates that a pair of dual-action monoclonal antibodies derived from

Read more

SARS-CoV-2 D614G mutation associated with lower antibody binding

The onset of the coronavirus disease 2019 (COVID-19) pandemic has brought about an international effort to uncover the biology of

Read more